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Abstract
Background: Sleep disruptions are common during pregnancy and associated with increased risk of adverse maternal outcomes
such as preeclampsia, gestational diabetes, prolonged labor, and cesarean birth. Given the morbidity associated with poor sleep,
cost-effective approaches to improving sleep that can be disseminated in community or clinical settings are needed. Personal
health monitor (PHM) devices offer an opportunity to promote behavior change, but their acceptability and efficacy at improving
sleep in pregnant women are unknown.
Objective: The goal of the paper is to describe the protocol for an ongoing pilot randomized controlled trial that aims to establish
the feasibility, acceptability, and preliminary efficacy of using a PHM device (Shine 2, Misfit) to promote sleep during pregnancy.
Methods: The proposed pilot study is a 12-week, parallel arm, randomized controlled trial. Pregnant women, at 24 weeks
gestation, will be randomized at a 1:1 ratio to a 12-week sleep education plus PHM device group or a sleep education alone
comparison group. The primary outcomes will be measures of feasibility (ie, recruitment, enrollment, adherence) and acceptability
(ie, participant satisfaction). The secondary outcomes will be self-reported sleep quality and duration, excessive daytime sleepiness,
fatigue, and depressive symptoms.
Results: Recruitment for this study began in September 2017 and ended in March 2018. Data collection for the primary and
secondary aims was completed in August 2018. We anticipate that the data analysis for primary and secondary aims will be
completed by December 2019. The results from this trial will inform the development of a larger National Institutes of Health
grant application to test the efficacy of an enhanced version of the sleep intervention that we plan to submit in the year 2020.
Conclusions: This study will be the first to apply a PHM device as a tool for promoting self-management of sleep among
pregnant women. PHM devices have the potential to facilitate behavioral interventions because they include theory-driven,
self-regulatory techniques such as behavioral self-monitoring. The results of the study will inform the development of a sleep
health intervention for pregnant women.
Trial Registration: ClinicalTrials.gov NCT03783663; https://clinicaltrials.gov/ct2/show/NCT03783663 (Archived by WebCite
at http://www.webcitation.org/779Ou8hon)
International Registered Report Identifier (IRRID): DERR1-10.2196/12455
(JMIR Res Protoc 2019;8(5):e12455)   doi:10.2196/12455
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Introduction
Sleep disruptions are common during pregnancy [1] and are
associated with an increased risk of adverse maternal/fetal
outcomes such as hyperglycemia [2,3], gestational diabetes [4],
preeclampsia [5], cesarean delivery [6], longer labor [7], and
delivering a low birthweight infant [8]. Additionally, women
with poor sleep in pregnancy experience increased depressive
symptoms during pregnancy [9] and postpartum depression
[10], which increase their risk of depression later in life [11].
While sleep disruptions among pregnant women are often due
to physical (eg, pain, nocturia, growing fetus) and hormonal
changes [12], lifestyle factors such as sleep hygiene (ie,
behavioral and environmental habits that promote or disrupt
sleep) also contribute to sleep disruptions. For example, in a
convenience sample of 197 pregnant women in their third
trimester of pregnancy in Taiwan, poor sleepers were shown to
have worse sleep hygiene than good sleepers [13]. Moreover,
other health behaviors, such as physical activity and diet, are
associated with better sleep duration in pregnancy [14-17].
These studies demonstrate that modifiable factors contribute to
sleep disruptions during pregnancy, suggesting that interventions
could make a positive impact on sleep in this group. A review
of seven nonpharmacological (eg, acupuncture, physical activity,
massage) sleep interventions during pregnancy showed trends
of improving sleep; however, the studies have generally been
of low quality and none focused on sleep hygiene [18]. Given
the scarcity of effective approaches to promote sleep among
pregnant women, there is a need to develop interventions that
can be easily disseminated in community or clinical settings.
Personal health monitors (PHMs) have grown in popularity,
with an estimated 1 in 8 consumers now owning a PHM [19].
The popularity of PHM use may provide an opportunity to
promote positive health behaviors, such as sleep health, on a
large scale. Many PHM devices include theory-driven behavior
change techniques such as self-monitoring, goal setting, review
of behavioral goals, rewards, and facilitation of comparisons
with peers [20]. Several researchers have incorporated the use
of PHMs into standard interventions to promote physical activity
and weight loss [21-26]. However, there is limited evidence on
the efficacy of wearable devices to promote sleep.
Here we describe the protocol for an ongoing pilot randomized
controlled trial [NCT03783663] that aims to establish the
feasibility, acceptability, and preliminary efficacy of using a
PHM device (Shine 2, Misfit) to promote sleep during
pregnancy. Specifically, the primary aim of the study will be
to (1) establish the feasibility and acceptability of conducting
a 12-week intervention for sleep self-management among
pregnant women using a PHM device and (2) determine the
feasibility of collecting data on sleep and physical activity using
a PHM device. The secondary aim will be to determine the
preliminary efficacy of the trial on improving self-reported sleep
quality and nocturnal sleep duration and decreasing sleep
disturbances, excessive daytime sleepiness, fatigue, and
depressive symptoms.
Methods
Study Design
This pilot study is a 12-week, parallel arm, randomized
controlled trial. Participants will be randomized at a 1:1 ratio
to a 12-week sleep education plus PHM device group or a sleep
education alone comparison group at approximately 24 weeks
gestation of pregnancy (Figure 1). This time period was chosen
to capture data during the third trimester of pregnancy when
sleep may worsen [1] while allowing sufficient time for study
completion prior to birth. We will use blocked randomization
to ensure equal group size due to the small pilot sample size.
The study has been approved by the institutional review board
of the University of Massachusetts Amherst. All participants
will be required to provide informed written consent prior to
enrollment.
Figure 1. Participant flowchart.
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Procedures
At the time of recruitment (t0) (14 to 24 weeks gestation),
participants will complete a screening survey to determine their
eligibility. At 24 weeks gestation (t1), eligible participants will
enroll in the study and complete a baseline survey to assess
demographic characteristics and secondary outcome measures.
Both researchers and participants will be blinded to group
assignment at the baseline assessment and during the educational
intervention. All participants will receive an individual
30-minute educational intervention on sleep hygiene during
pregnancy delivered by a study registered nurse at enrollment.
The focus on the sleep education will be to provide tips on how
to achieve a better night’s sleep during pregnancy such as
managing pregnancy weight gain with aerobic activity and
keeping a consistent schedule. Participants will also receive a
sleep hygiene brochure, adapted from a Massachusetts Lung
and Allergy sleep clinic sleep hygiene brochure to include
information specific to pregnancy. We piloted the development
of the brochure through an online survey that asked about the
usefulness of the information and overall aesthetics. We used
similar recruitment approaches (ie, Facebook) and eligibility
criteria to identify women in the brochure development pilot as
will be used for the pilot intervention to ensure the feedback is
appropriate for the target population. Based on the participant
feedback, we made modifications to the brochure’s graphical
design; the information content was deemed useful. After
completing the baseline survey and sleep hygiene education,
participants and researchers will be unblinded to the group
assignment (t2). Assignments will be made prior to the start of
recruitment by randomizing study identification (ID) numbers
into intervention or control group using Web-based
randomization software [27]. The results of the randomization
process will be placed into individually sealed envelopes labeled
with study ID numbers. At t2, the study nurse will open the
envelope for the ID number assigned to the participant and
reveal group assignment. Those in the intervention group will
then receive the intervention.
At 36 weeks gestation (t3), all participants will complete an
in-person follow-up survey to assess the same secondary
outcome measures as at t1. Participants will also complete a
brief qualitative interview to determine their satisfaction with
the sleep hygiene education and, for those in the intervention
group, the self-monitoring intervention. Participants will
complete a final follow-up phone survey approximately 2 to 4
weeks after delivery (t4).
Study Population
We will recruit pregnant women who reside within
approximately 50 miles of the University of Massachusetts
Amherst campus. To be eligible to participate in the study, at
the time of recruitment (t0) women must (1) be aged 18 years
or older, (2) be 14 to <24 completed weeks gestation, (3) have
no known maternal or fetal complications, (4) have a mobile
phone compatible with the study PHM device, (5) have internet
access, (6) be English speaking, and (7) be receiving prenatal
care. We will exclude women with preexisting diabetes mellitus,
hypertension, or a diagnosed sleep disorder, as some research
demonstrated that associations between gestational diabetes and
hypertension and a preexisting diagnosed sleep disorder would
bias study results [28]. For the purpose of establishing feasibility
and acceptability of recruitment and implementing the
intervention, the sample size goal is 10 women per group. To
account for attrition, we will oversample by 20%, recruiting 12
women per group.
Recruitment will be conducted through advertisements posted
(1) at local commercial and community centers frequented by
pregnant women in western MA, (2) at a women’s health clinic
in western MA, (3) at community centers with diverse
memberships such as churches, and (4) on Facebook and
Craigslist. The study nurse will also recruit participants in person
in the waiting room of the women’s health clinics at the
University of Massachusetts Medical Center. During
screening/enrollment, we will document the source of
recruitment for each participant.
Intervention
Conceptual Framework
The conceptual framework for the intervention is based on a
meta-regression of lifestyle (ie, healthy eating and physical
activity) interventions among adults by Michie et al [29]. The
authors found that lifestyle interventions incorporating
self-monitoring and one other self-regulatory technique derived
from control theory (ie, intention formation, setting goals,
feedback on performance, review of behavioral goals) were
more effective at promoting behavior change (pooled effect size
= 0.38; 95% CI 0.27 to 0.49) than studies not including these
techniques (pooled effect size = 0.27; 95% CI 0.21 to 0.34).
Likewise, in their systematic review and meta-analysis on the
efficacy of postpartum physical activity interventions, Gilinsky
et al [30] found that efficacious interventions were twice as
likely to include self-monitoring than nonefficacious
interventions. Guided by this conceptual framework, the sleep
intervention will include (1) behavioral self-monitoring (using
the Shine 2), (2) goal setting (30-minute sleep education
session), (3) feedback on performance (Shine 2), and (4) review
of behavioral goals (Shine 2).
Instrumentation
The intervention group will be given a Shine 2 to monitor sleep
throughout the 12-week intervention period. The Shine 2 is a
triaxial accelerometer that can be worn on the wrist, waist, neck,
pocket, or shoe. The Shine 2 measures steps, intensity, energy
expenditure, distance traveled, and sleep duration using a
proprietary algorithm. The Shine 2 was selected because it can
be worn continuously (even during water-based activities), does
not require charging (approximate 6-month battery life), and
does not require participants to set the device to sleep mode in
order to capture sleep patterns, features that may improve
adherence to the intervention. The Shine 2 has been shown to
provide equivalent estimates of total sleep time as in-lab
polysomnography (r=.87), the gold standard for sleep assessment
[31].
Participants will be instructed to wear the device on the wrist,
which is better for capturing sleep than the other wear locations.
Participants will be instructed on how to self-monitor total sleep
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time and select a goal for that behavior. Figures 2 and 3 show
examples of the feedback participants receive on their sleep
relative to their self-selected sleep goals. Further, participants
will view feedback on their sleep time daily on the Shine 2
mobile phone app, which they can use to monitor their progress
toward achieving their behavioral goals. The Shine 2 syncs with
iPhone, Android, and Windows phones. Instructions for syncing
the Shine 2s to phones will be included in an instructional
brochure designed by the study team. Study-specific Gmail
accounts and passwords will be created for each study ID so
we can access their sleep and physical activity data. Participants
will download the Shine 2 app to their mobile phone and create
a Shine 2 account using the assigned study Gmail address.
Participants will also download the IFTTT app, a free platform
that facilitates downloading and sharing data from a PHM [32].
Participants will activate two IFTTT applets that connect Shine
2 with a Google spreadsheet in Google Drive: (1) “Save your
Misfit Shine 2 sleep logs to a Google spreadsheet” and (2)
“Document your daily activity summaries.” The applets will
automatically download the Shine 2 data for sleep daily to the
participant’s study Gmail account, making it viewable by the
research team. This will allow the research team to view
participant progress toward meeting their sleep goals. To
enhance data security, the study Gmail account will be used
only to collect the Shine 2 data (ie, will not be used for email
or other purposes), and the Google Drive accounts will be
accessed only by study team members using computers that are
password-protected and encrypted. Further, no identifying
personal information will be contained within the Gmail account.
At the end of the study, participants will be instructed to change
their email addresses and passwords in their Shine 2 account to
a personal email and password so investigators will no longer
have access to their Shine 2 accounts. Once all Shine 2 data
have been extracted from the study Google Drive accounts, the
accounts will be closed. A team member will conduct follow-up
calls to intervention participants one week after enrollment and
then monthly to address any issues with using the study device
and to answer questions.
Figure 2. Misfit Shine 2 dashboard displaying the previous night’s sleep duration and self-selected sleep goal.
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Figure 3. Misfit Shine 2 dashboard displaying weekly trend of sleep duration and self-selected sleep goal.
Intervention Fidelity
The sleep hygiene education session will be provided to both
groups by the study nurse. To increase fidelity, a specific
protocol for delivering the education to each group will be
developed by the principal investigator, and the study nurse will
be trained by the principal investigator on the protocol. The
delivery of education to study participants will be audio recorded
with a digital recorder. The principal investigator will listen to
each recording to ensure that participants are receiving the same
information per the protocol. In the event that deviation from
the protocol is noted, the principal investigator and study nurse
will meet to review and retrain on the protocol.
Primary Outcomes: Intervention, Feasibility, and
Acceptability
Table 1 describes the schedule of study assessments for primary
and secondary outcomes measures.
Recruitment
At t0, participants will be asked how they learned about the
study (eg, Facebook, community center), with follow-up
questions to gather specific details as necessary. The frequency
and percentage of participants recruited by each recruitment
method will be calculated. We will present descriptive data on
the number screened, eligible, and randomized from each source.
Retention
Retention may be a challenge due to the longitudinal nature of
the study. Each participant will be asked to provide multiple
contact methods. Increasing incentives will be built into the
study at each data collection time point ($20, $30, and $40 gift
cards) to encourage retention for both the intervention and
control groups. Participants in the intervention arm will keep
the Shine 2 device at the study end. Participants in the control
arm will be offered a Shine 2 at the study end. The ability to
successfully contact participants, deliver the intervention, and
collect data at each time point will be recorded to calculate the
percentage of participants retained.
To evaluate participant retention with the intervention protocol,
the study team will take two actions. First, we will track sleep
data weekly for each participant by viewing their sleep log in
the study Gmail account. Then, if a lack of data in the sleep log
suggests that the participants are not wearing the monitor daily,
we will call the participants to find out why they are not using
the device, help them problem solve any issues, and encourage
them to continue with study adherence.
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Table 1. Schedule of study assessments for primary and secondary outcomes.
AssessmentCharacteristics
Active interventionBaselineScreening/enrollment 
t3t2t1t0 
Primary outcomes
Recruitment/enrollment 
XEligibility screen  
XInformed consent  
XAllocation  
XRetention  
XParticipant satisfaction  
Secondary outcomes
XXSleep quality and duration 
XXSleep disturbances 
XXExcessive daytime sleepiness 
XXFatigue 
XXDepressive symptoms 
Participant Satisfaction
Participants in both groups will be asked to complete a
semistructured interview at the 12-week follow-up data
collection meeting (t3). The interview questions will ask
participants about their sleep, barriers and facilitators of sleep,
and whether the brief sleep counseling was helpful. Women in
the intervention group will additionally be asked about their
experience wearing the Shine 2, their likes, dislikes, and whether
they believe it would be helpful to other pregnant women.
Secondary Outcomes
Sleep Quality and Duration
The Pittsburgh Sleep Quality Index (PSQI) will be used to
measure sleep quality and duration [33]. The PSQI is a 19-item
scale measuring perceived sleep quality and disturbance over
the past month. For this study, the PSQI will be adapted to
measure perceived sleep quality over the past week. The PSQI
has been used in numerous studies with pregnant women and
has been validated for pregnant women using confirmatory
factor analysis and has a reliability of .74 [34]. Scores ≥5 will
be considered indicative of poor sleep.
Sleep Disturbances
The PROMIS Short Form v1.0–Sleep Disturbance 6a will be
used to measure sleep disturbances [35]. This validated 6-item
scale measures individual perceptions of sleep quality and
disturbance in the past seven days using a 5-point Likert scale.
It is scored by summing responses for all items (two are reverse
scored); higher scores indicate higher sleep disturbance.
Excessive Daytime Sleepiness
The Epworth Sleepiness Scale is an 8-item measure of daytime
sleepiness [36]. It has been validated for measuring symptoms
of daytime sleepiness in pregnant women using principal
components and confirmatory factor analysis and has a reliability
coefficient of .75 [37]. Higher cumulative scores indicate higher
sleepiness.
Fatigue
The PROMIS Fatigue Short Form 4a will be used to measure
fatigue. This 4-item scale measures fatigue in the past seven
days with a 5-point Likert scale [38]. Responses for all items
are summed; higher scores indicate higher fatigue symptoms.
Depressive Symptoms
Two scales will be used to measure depressive symptoms in the
past seven days. The PROMIS Depression Short Form 6a is a
6-item scale scored by summing responses for all items, with
higher scores indicating higher depressive symptoms. It has
been validated for use with several chronic illnesses [39].
Although this scale has not been validated in pregnant women,
it is a common data element measurement tool that is supported
by the National Institutes of Heath. This will allow us to upload
deidentified data gathered with this tool to the National Institute
for Nursing Research Common Data Elements Repository. We
will additionally measure sleep using the Edinburgh Postnatal
Depression Scale, a 10-item scale designed to detect depressive
symptoms in postpartum women [40], with support for detection
of depressive symptoms in pregnancy [41]. Scores range from
0 to 30; a higher score indicates higher depressive symptoms.
We will use scores >12 to indicate depressive symptoms.
Covariates
We will collect information on demographic characteristics and
eating habits. Demographic characteristics will include age,
ethnic background, racial background, relationship status, level
of education, employment status, hours worked per week, and
income level. Eating habits will be measured using the Dietary
Targets Monitor, a 9-item self-report questionnaire assessing
consumption of fruits, vegetables, starchy foods, and other types
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of foods such as meat and fish [42]. Recommended standard
portion for each group will be used to calculate daily, weekly,
and monthly consumptions of different foods [42].
Data Analysis
We will use descriptive statistics to determine the feasibility
and acceptability of the pilot intervention. Specifically, we
describe recruitment and dropout rates in each group and
noncompliance with the intervention among the intervention
group only. To assess noncompliance we will use data from the
IFTTT applet to determine the proportion of days the monitor
was worn during the study period. High compliance will be
defined as wearing the monitor at least 80% of days during the
study period.
Qualitative methods will be used to determine the acceptability
of the intervention, using a qualitative descriptive design [43,44].
The audio recorded interviews will be organized using NVivo
11 (QSR International Inc) software. Recordings will be
professionally transcribed verbatim, and transcripts will be
checked for accuracy. Descriptive coding will be used to identify
and link comparable content and categorize data at a basic level
[43]. For further analysis of descriptive codes, content analysis
will be used to describe patterns and summarize findings in the
data [44]. Memos will be written throughout the analytic process
to capture the analysis process and the researchers’ responses
to the data. Trustworthiness will be determined through peer
debriefing between the research assistant and the principal
investigator and the audit trial of documentation of the analysis,
including coding, memos, and findings.
To examine the preliminary efficacy of the intervention, all
secondary outcome variables will be modeled as continuous
outcomes. We will compare baseline characteristics of the
intervention groups to ensure randomization was successful.
We will present the mean and standard deviation or median and
interquartile range for each secondary outcome at baseline and
postintervention. A paired t test will be used to compare baseline
and postintervention means separately in each group. A Student
t test will then compare the change in each measure between
the two intervention groups. Finally, we will calculate within
and between-group effect sizes using Cohen d (MΔI – MΔC /
SDpooled I and C; Mt2 – Mt3 / SDpooled t2 and t3).
Results
Recruitment for this study began in September 2017 and ended
in March 2018. Data collection for the primary and secondary
aims was completed in August 2018. We anticipate that the data
analysis for primary aims, evaluating the feasibility and
acceptability of the intervention, will be completed by July
2019. We anticipate that the data analysis on the secondary
aims, examining the preliminary efficacy of the trial on sleep
quality and duration, sleep disturbance, excessive daytime
sleepiness, fatigue, and depressive symptoms, will be completed
by December 2019. The results from this trial will inform the
development of a larger National Institutes of Health grant
application to test the efficacy of an enhanced version of the
sleep intervention that we plan to submit in the year 2020.
Discussion
Principal Findings
This 12-week, parallel arm, pilot randomized controlled trial
proposes to establish the feasibility and acceptability of
conducting a 12-week intervention for sleep self-management
among pregnant women using a PHM device and determine the
feasibility of collecting data on sleep and physical activity using
a PHM device. Secondarily, the trial will determine the
preliminary efficacy of the trial on improving self-reported sleep
quality and nocturnal sleep duration and decreasing sleep
disturbances, excessive daytime sleepiness, fatigue, and
depressive symptoms. This study is novel because it will be the
first to apply a PHM device as a tool for promoting
self-management of sleep among pregnant women. We
anticipate that at least 80% of participants will wear the PHM
device daily throughout the study period and report high
satisfaction with the intervention. Further, we anticipate that
participant feedback will inform the design of a larger
randomized controlled trial aiming to improve sleep quality and
duration during pregnancy using a PHM device.
Specifically, findings from the pilot study will inform the
recruitment and intervention implementation, including
strategies to increase adherence. As far as refining our
recruitment plan, we will learn important information about the
demographic characteristics (eg, race and ethnicity,
socioeconomic status, baseline sleep characteristics) of the
sample population. Our recruitment goal is for at least 20% of
the sample to come from racial and ethnic minority groups. If
we fail to recruit a racial and ethnically diverse sample, we will
identify specific recruitment barriers and refine our recruitment
strategy. Second, we will identify which recruitment approach
(eg, Facebook, flyering at local clinics) is the most cost effective.
Third, identifying weekly and monthly recruitment yields will
allow us to determine if our recruitment strategy could feasibly
enroll participants for an adequately powered study. We will
need to consider the length of the recruitment period, adding
clinical sites, and budgetary considerations for the larger trial.
In addition to recruitment, participant adherence is another
critical challenge this feasibility study will help inform. Since
previous studies did not use a PHM device specifically to
monitor sleep, we would like to first address if pregnant women
will wear them for this purpose. Through the IFTTT app, we
will be able to identify when the monitor is not worn and elicit
feedback from participants on any barriers to wearing the device.
If specific benchmarks for retention are not met (>80%), we
will refine our current approach (eg, incentive, engagement
strategies) to address any challenges that exist.
Last, this feasibility trial will provide important information
about the implementation of the intervention. The intervention
was meant to be a low-contact intervention to be consistent with
the limited time resources in a clinic setting. Through the
participant satisfaction interview, we will determine whether
the initial counseling session and sleep brochure address
challenges specific to pregnant women. Concerning the
instruments for the intervention (Shine 2), we will learn if there
are specific features participants liked or did not like about the
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device and the extent to which participants used the device to
self-monitor their sleep. Identifying specific features will allow
us to be responsive to rapid changes in technology, steering us
to select a device that contains features participants find
particularly helpful. More generally, we will learn if wearing
the PMH device serves as a motivator to participants to monitor
their sleep more closely and identify behaviors affecting their
sleep.
Given the prevalence and morbidity of sleep disturbances during
pregnancy, it is essential to identify cost-effective approaches
to promote better sleep in this group. Wearable devices have
the potential to facilitate behavioral interventions as they include
theory-driven self-regulatory techniques such as behavioral
self-monitoring. There has been increasing interest in
incorporating PMH devices into clinical settings. For example,
PHM devices have been used to monitor inpatient recovery [45].
In an outpatient care setting, PHM devices can be used to track
health behaviors remotely and monitor progress toward meeting
patient-centered goals around sleep [46,47]. Data from PHM
devices can be integrated into electronic medical records. For
the patient, tracking behavior more closely can help the patient
identify patterns and make choices to change behavior to
improve sleep [48]. No prior studies have used a PHM to
promote sleep during pregnancy; therefore, novel intervention
strategies need to be developed and refined.
Limitations
This study will, however, have important limitations that warrant
discussion. First, the study requires that participants have access
to mobile phones compatible with the study monitor; therefore,
individuals of low socioeconomic status may potentially be
excluded from the study [49]. However, lower income
Americans have made gains in technology adoption including
the use of mobile phones, which is likely to continue in the
future. In addition, since there are multiple components of the
intervention (ie, PHM and follow-up calls), we will not be able
to discern which component explains differences between the
groups, if any are observed. We will keep the follow-up calls
briefs and use them primarily as a method of collecting
information on the study’s feasibility throughout. However, we
won’t be able to remove the potential effects repeated contacts
can have on a participant’s ability to change behavior. Third,
we will not exclude participants based on their use of any PHM.
Therefore, control group participants may have access to a PHM
during the study. However, none of the participants will be using
our specific study monitor at baseline. Further, participants in
the control group will receive study monitors at the end of the
study to reduce attrition and limit the use of PHMs during the
study. Last, due to the small sample size, we will not have
sufficient power to detect any group differences in the secondary
outcomes. Therefore, any significant or nonsignificant findings
must be interpreted with caution. We will, however, be able to
observed trends and generate hypotheses to be tested in a fully
powered study.
Conclusion
This pilot feasibility study will provide the foundation for a
larger trial that aims to improve sleep during pregnancy using
a PHM device. The findings from this feasibility and
acceptability pilot will provide valuable feedback on the design
and implementation of the intervention.
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